NO2011019I1 - Vaksine omfattende antigenet PRP-T koplet til et tetanus anatoksin - Google Patents

Vaksine omfattende antigenet PRP-T koplet til et tetanus anatoksin

Info

Publication number
NO2011019I1
NO2011019I1 NO2011019C NO2011019C NO2011019I1 NO 2011019 I1 NO2011019 I1 NO 2011019I1 NO 2011019 C NO2011019 C NO 2011019C NO 2011019 C NO2011019 C NO 2011019C NO 2011019 I1 NO2011019 I1 NO 2011019I1
Authority
NO
Norway
Prior art keywords
vaccine
linked
tetanus anatoxin
antigen
prp
Prior art date
Application number
NO2011019C
Other languages
English (en)
Other versions
NO2011019I2 (no
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9479510&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2011019(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Publication of NO2011019I1 publication Critical patent/NO2011019I1/no
Publication of NO2011019I2 publication Critical patent/NO2011019I2/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
NO2011019C 1995-05-24 2011-09-19 Vaksine omfattende antigenet PRP-T koplet til et tetanus anatoksin NO2011019I2 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9506417A FR2734484B1 (fr) 1995-05-24 1995-05-24 Composition vaccinale liquide et procede de fabrication
PCT/FR1996/000791 WO1996037222A1 (fr) 1995-05-24 1996-05-24 Composition vaccinale comprenant du polyribosylribitol phosphate et son procede de fabrication

Publications (2)

Publication Number Publication Date
NO2011019I1 true NO2011019I1 (no) 2011-09-26
NO2011019I2 NO2011019I2 (no) 2015-05-18

Family

ID=9479510

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19975366A NO319579B1 (no) 1995-05-24 1997-11-21 Vaksine sammensetning inneholdende hoymolekylaert polyribosylribitolfosfat, og fremgangsmate for fremstilling derav
NO2011019C NO2011019I2 (no) 1995-05-24 2011-09-19 Vaksine omfattende antigenet PRP-T koplet til et tetanus anatoksin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19975366A NO319579B1 (no) 1995-05-24 1997-11-21 Vaksine sammensetning inneholdende hoymolekylaert polyribosylribitolfosfat, og fremgangsmate for fremstilling derav

Country Status (26)

Country Link
US (1) US6333036B1 (no)
EP (1) EP0828511B1 (no)
JP (1) JPH11505824A (no)
KR (1) KR100404312B1 (no)
CN (1) CN1152715C (no)
AT (1) ATE207365T1 (no)
BR (1) BR9608810C8 (no)
CA (1) CA2218764C (no)
CZ (1) CZ289810B6 (no)
DE (2) DE69620271T2 (no)
DK (1) DK0828511T3 (no)
EA (1) EA000411B1 (no)
ES (1) ES2162067T3 (no)
FR (1) FR2734484B1 (no)
GR (1) GR3037011T3 (no)
HK (1) HK1017251A1 (no)
HU (1) HU223941B1 (no)
LU (1) LU91924I2 (no)
NL (1) NL300231I2 (no)
NO (2) NO319579B1 (no)
NZ (1) NZ309829A (no)
PL (1) PL185846B1 (no)
PT (1) PT828511E (no)
SK (1) SK282500B6 (no)
TR (1) TR199701424T1 (no)
WO (1) WO1996037222A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
US6974581B1 (en) * 1998-12-15 2005-12-13 Aventis Pasteur Limited Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
IL145209A0 (en) 2000-09-06 2002-06-30 Pfizer Prod Inc Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
EP1674087A1 (en) 2000-10-02 2006-06-28 Pfizer Products Inc. Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists
FR2828406B1 (fr) * 2001-08-08 2005-06-24 Aventis Pasteur Composition vaccinale bivalente havi
ATE492288T1 (de) 2002-10-11 2011-01-15 Novartis Vaccines & Diagnostic Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien
JP4827726B2 (ja) 2003-01-30 2011-11-30 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル 複数の髄膜炎菌血清群に対する注射可能ワクチン
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
CN103357002A (zh) 2003-10-02 2013-10-23 诺华疫苗和诊断有限公司 多种脑膜炎球菌血清群的液体疫苗
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
WO2005051919A1 (en) * 2003-11-26 2005-06-09 Pfizer Products Inc. Aminopyrazole derivatives as gsk-3 inhibitors
GB0405787D0 (en) * 2004-03-15 2004-04-21 Chiron Srl Low dose vaccines
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
RU2379052C2 (ru) 2004-04-30 2010-01-20 Чирон С.Р.Л. Вакцинация менингококковыми конъюгатами
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
JP2010534622A (ja) * 2007-07-26 2010-11-11 サノフィ パストゥール リミテッド 抗原−アジュバント組成物および方法
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
PE20100365A1 (es) * 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion
PE20100366A1 (es) 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion
US7814991B2 (en) * 2009-01-28 2010-10-19 Gas Technology Institute Process and apparatus for subterranean drilling
CN104548082A (zh) 2009-03-24 2015-04-29 诺华股份有限公司 为脑膜炎球菌因子h结合蛋白添加佐剂
MX2012011340A (es) * 2010-03-29 2012-11-16 Novartis Ag Composicion que comprende el peptido amiloide beta 1-6acoplado a una particula similar a virus y un auxiliar.
US10092640B2 (en) 2011-01-05 2018-10-09 Bharat Biotech International Limited Combination heptavalent vaccine
EA030749B1 (ru) 2013-03-08 2018-09-28 Янссен Вэксинс Энд Превеншн Б.В. Бесклеточная противококлюшная вакцина
KR20230173114A (ko) 2021-04-20 2023-12-26 케이엠 바이올로직스 가부시키가이샤 6종 혼합 액상 백신 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
EP0320942A3 (en) * 1987-12-18 1989-10-04 American Cyanamid Company Novel polysaccharides novel macromolecular conjugates of the polysaccharides
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
NZ253065A (en) * 1992-05-23 1996-10-28 Smithkline Beecham Biolog Combination vaccines comprising hepatitis b surface antigens and other antigens wherein aluminium phosphate adjuvant is used to adsorb the hepatitis antigen

Also Published As

Publication number Publication date
ES2162067T3 (es) 2001-12-16
GR3037011T3 (en) 2002-01-31
NZ309829A (en) 1999-06-29
NO975366L (no) 1997-11-21
FR2734484B1 (fr) 1997-06-27
TR199701424T1 (xx) 1998-03-21
DE122011100030I1 (de) 2011-12-08
CA2218764A1 (fr) 1996-11-28
EP0828511A1 (fr) 1998-03-18
FR2734484A1 (fr) 1996-11-29
EA000411B1 (ru) 1999-06-24
AU708777B2 (en) 1999-08-12
WO1996037222A1 (fr) 1996-11-28
HK1017251A1 (en) 1999-11-19
CZ289810B6 (cs) 2002-04-17
NO319579B1 (no) 2005-08-29
BR9608810C8 (pt) 2014-07-08
PL323457A1 (en) 1998-03-30
HUP9901432A2 (hu) 1999-08-30
EP0828511B1 (fr) 2001-10-24
CZ359797A3 (cs) 1999-06-16
US6333036B1 (en) 2001-12-25
NL300231I2 (nl) 2006-09-01
BR9608810A (pt) 1999-08-31
MX9709011A (es) 1998-03-31
ATE207365T1 (de) 2001-11-15
CA2218764C (fr) 2011-01-11
SK282500B6 (sk) 2002-10-08
HUP9901432A3 (en) 2000-03-28
NO2011019I2 (no) 2015-05-18
PL185846B1 (pl) 2003-08-29
KR100404312B1 (ko) 2004-02-11
NL300231I1 (nl) 2006-07-03
KR19990014919A (ko) 1999-02-25
LU91924I2 (fr) 2012-02-21
CN1152715C (zh) 2004-06-09
AU6008696A (en) 1996-12-11
HU223941B1 (hu) 2005-03-29
EA199700419A1 (ru) 1998-06-25
DE69620271T2 (de) 2002-07-18
NO975366D0 (no) 1997-11-21
PT828511E (pt) 2002-02-28
JPH11505824A (ja) 1999-05-25
SK152997A3 (en) 1998-07-08
DK0828511T3 (da) 2002-02-18
CN1190898A (zh) 1998-08-19
DE69620271D1 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
NO2011019I1 (no) Vaksine omfattende antigenet PRP-T koplet til et tetanus anatoksin
ATE446107T1 (de) Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n- acryloyliertem polysaccharid
FI104046B (fi) Menetelmä konjugoidun oligosakkaridin valmistamiseksi
ATE19734T1 (de) Heamophilus influenzae b polysaccharid exotoxoid konjugat-impfstoff.
EP0914153B8 (en) Multivalent dtp-polio vaccines
IS3753A7 (is) Endurbætt aðferð og samsetning bóluefnis
ATE70187T1 (de) Glycoproteinkonjugate mit trivalenter immunogener aktivitaet.
ES2000140A6 (es) Procedimiento para preparar vacunas conjugadas no toxicas contra infecciones por bacterias gram-negativas
EP0320942A3 (en) Novel polysaccharides novel macromolecular conjugates of the polysaccharides

Legal Events

Date Code Title Description
MK1K Patent expired